Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENOFOVIR ALAFENAMIDE for Prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where TENOFOVIR ALAFENAMIDE was used for Prophylaxis.

Most Reported Side Effects for TENOFOVIR ALAFENAMIDE

Side Effect Reports % Deaths Hosp.
Death 217 7.3% 214 2
Product dose omission issue 153 5.1% 4 18
Off label use 96 3.2% 8 31
Drug ineffective 93 3.1% 5 13
Fatigue 92 3.1% 1 8
Headache 71 2.4% 0 6
Product dose omission 69 2.3% 0 2
Intentional dose omission 67 2.2% 0 5
Product use issue 67 2.2% 0 6
Nausea 64 2.1% 1 7
Diarrhoea 60 2.0% 4 21
Maternal exposure during pregnancy 58 1.9% 0 4
Foetal exposure during pregnancy 52 1.7% 7 9
Neoplasm malignant 52 1.7% 9 11
Hepatitis b 48 1.6% 3 16

Other Indications for TENOFOVIR ALAFENAMIDE

Hepatitis b (935) Product used for unknown indication (757) Chronic hepatitis b (679) Hiv infection (197) Hepatitis viral (38) Acute hepatitis b (36) Antiretroviral therapy (24) Hepatic cirrhosis (23) Hepatitis b reactivation (21) Acquired immunodeficiency syndrome (15)

Other Drugs Used for Prophylaxis

PEGFILGRASTIM (7,424) HUMAN C1-ESTERASE INHIBITOR (5,950) DENOSUMAB (4,541) SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197) ASPIRIN (2,083) VALACYCLOVIR (1,574) PANTOPRAZOLE (1,502) VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444) CLOPIDOGREL BISULFATE (1,296) ENOXAPARIN (1,278)

Related Pages

TENOFOVIR ALAFENAMIDE Full Profile All Prophylaxis Drugs TENOFOVIR ALAFENAMIDE Demographics TENOFOVIR ALAFENAMIDE Timeline